Plain-English translation of NCT06599528 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing whether SJ04, a new fertility hormone injection, works the same way in your body as Ovidrel®, an existing fertility medication. Both are versions of a hormone used to help with fertility treatments. The study will measure how your body absorbs, processes, and eliminates each medication to confirm they are truly similar.
SJ04 is a newly developed version of an existing fertility medication. Before doctors can offer this treatment to patients, researchers need to confirm that it behaves identically to the original medication in the body—this ensures it will be just as safe and effective.
You likely qualify if…
You likely don't qualify if…
You will receive two single injections under the skin, each containing 250 micrograms of hormone medication—one injection of each type. The two injections will be given at least 2 weeks apart so your body can fully recover between them. During the study, you will have blood drawn multiple times to measure hormone levels and ensure the medications are being processed safely by your body.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
China